Skip to main content

Table 1 Clinicopathological characteristics of patients with RCC

From: Increased level of serum leucine-rich-alpha-2-glycoprotein 1 in patients with clear cell renal cell carcinoma

 

ccRCC (N = 64)

non ccRCC (N = 22)

p value

M / F

37 (58%) / 27 (42%)

14 (64%) / 8 (36%)

0.63

Age, median

62.5 (35-87)

60.5 (23-82)

0.49

TNM classification

   

clinical T

  

0.42

1

50 (78%)

19 (86%)

 

2

5 (8%)

2 (9%)

 

3

9 14%)

1 (5%)

 

4

0

0

 

clinical N

  

0.06

0

64 (100%)

20 (90%)

 

1

0

1 (5%)

 

2

0

1 (5%)

 

clinical M

  

0.97

0

58 (91%)

20 (90%)

 

1

6 (9%)

2 (10%)

 

Grading

  

0.18

1

8 (13%)

1 (5%)

 

2

49 (76%)

14 (64%)

 

3

6 (9%)

5 (22%)

 

N.A.

1 (2%)

2 (9%)

 

pathological T

  

0.13

1

47 (74%)

19 (86%)

 

2

6 (9%)

0

 

3

11 (17%)

3 (14%)

 

4

0

0

 

INF

  

0.15

a

47 (73%)

20 (90%)

 

b

15 (24%)

2 (10%)

 

c

0

0

 

N.A.

2 (3%)

0

 

v

  

0.31

0

46 (72%)

19 (86%)

 

1

17 (16%)

3 (14%)

 

N.A.

1 (2%)

0

 

Tumor size (cm)

3.5 (2.23 - 5.85)

2.9 (2.23 - 4.55)

0.41

CRP (mg/dl)

0.13 (0.1-0.43)

0.1 (0.1-0.81)

0.90

LRG1 (ug/ml)

63.2 (42.8 - 94.2)

23.4 (17.7 - 29.6)

<0.0001